Sam Blackman

Pediatric oncologist. Cancer drug developer.
Founder and former Head of R & D @DayOneBio.
Now tweeting at @drsam.bsky.social (instead of this hellsite) #resist

[Sam Blackman @drsam]

Hey folks, for what it’s worth, I’m now firmly established on Bluesky. Hope to see you there soon!

[Sam Blackman @drsam]

@ronalfa @srikosuri Yes. Happy to help. Please DM me with your email and cell #.

[Sam Blackman @drsam]

The irony that @NYTGames left #GenX out of a puzzle about generations with the theme “generation gap” is so f’ing rich …

#okboomer @nytimes #whatever

[Sam Blackman @drsam]

Tell your Senators: Oppose Kennedy for Health and Human Services Secretary 👇

https://t.co/yQzpn1AOAZ via @TheDemCoalition

#ResistTrump

[Sam Blackman @drsam]

Twitter: you kinda/sorta got mentioned in my end of year Top Ten list.

Kinda.

Sorta.

https://t.co/edkk88B6jz

[Sam Blackman @drsam]

Hey team @BiotechCH: when are you going to move over to Bluesky? Y’all should probably claim an account, even if it’s a placeholder.

[Sam Blackman @drsam]

I'll have more to say about it in the coming days. Those of you who know me know that I'll write something longer. I want to simply say thank you to everyone who, over the past 6-1/2 years, helpd made the dream of
@DayOneBio into a reality.

https://t.co/5BpIKPBdch

[Sam Blackman @drsam]

I’m kvelling.

[Yagdil Isn't Brisk @Briskerov]

🧵I asked @grok to imagine the last 5 Presidents as Orthodox Rabbis, here’s what I got:

1. Joe Biden

[Sam Blackman @drsam]

I see what you did there. @GovTimWalz @KamalaHarris #doritos

[Sam Blackman @drsam]

Last day of 55. Happy to start the next year with hope (thank you @KamalaHarris and @GovTimWalz), mission and passion (thank you @DayOneBio), a goal (thank you @ldtimmerman), friends, and of course, my family.

[Day One Biopharmaceuticals @DayOneBio]

Day One is thrilled to be featured in Times Square today! The expansion of our pipeline with DAY301 is an exciting milestone to further our mission to bring ground-breaking treatments to people of all ages with cancer.

[Sam Blackman @drsam]

We’re thrilled to expand our pipeline and we look forward to bringing this new molecule into the clinic. I am also very excited to work on ADCs again. Understanding of this therapeutic class has grown significantly over the past 10yrs. I’m excited to put that knowledge to work!

[Day One Biopharmaceuticals @DayOneBio]

Today, we announced the expansion of our pipeline with a clinical-stage ADC targeting PTK7 in solid tumors for adult & pediatric cancers. DAY301 is a continuation of our mission to transform outcomes for patients of all ages living with cancers. https://t.co/plzrj3k286

[Sam Blackman @drsam]

Fabulous way to start #ASCO24! @AACRPres and @ranjitbindra in the house. I also had a Marge spotting last night (but no selfie). @AACR

[Sam Blackman @drsam]

Let's *hope* that this weather forecast is accurate as it will make #ASCO24 a joy (I hate a muggy, hot ASCO, with those 4p thunderstorms when people are trying to rush from McCormick to downtown).

[Day One Biopharmaceuticals @DayOneBio]

During #BrainTumorAwarenessMonth, we’re committed to shining a light on the profound impact the disease has on children and their families, and the crucial need for more research, treatment options, and support. Join us in raising awareness as we #GoGrayInMay

[Sam Blackman @drsam]

Waiting to see if VHs “Eruption” shows up in this playlist.

[Sam Blackman @drsam]

Ok. An opening set of all instrumental tracks is pretty cool. Took me 15 minutes too hear that’s what you were doing. Truly showing why #MusicMatters. Thanks @djjohnrichards and @kexp for another fantastic morning on the 7th best day of the week.

[Sam Blackman @drsam]

@DrSarcoma @drbirgularslan @LifeSciVC @JacobPlieth @SFBIZronleuty @JuliePapanek @DFCI_ChemBio @DanaFarber @DFBC_PedCare @DayOneBio For more you can listen to us discuss the program on @ldtimmerman's podcast The Long Run:

https://t.co/8GzqVmemHw

[Sam Blackman @drsam]

@DrSarcoma @drbirgularslan @LifeSciVC @JacobPlieth @SFBIZronleuty @JuliePapanek @DFCI_ChemBio @DanaFarber @DFBC_PedCare @DayOneBio We saw a few of the responses from the first part of the PNOC014 trial and it confirmed our belief: this could be a drug for pLGG patients. With that, we set to work to negotiate for the drug, and the rest is history.